Heavy incense burning in temples promotes exposure risk from airborne PMs and carcinogenic PAHs

Science of the Total Environment

Volumn 372, Issue 1, 2006, Pages 64-75

  Chiang, Kuo Chih ^a   Liao, Chung Min ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

HRT model; Incense burning; Particulate matters; PBPK model; Polycyclic aromatic hydrocarbons; Risk assessment; Temple

Indexed keywords

PARTICLES (PARTICULATE MATTER); PHARMACOKINETICS; PHYSIOLOGICAL MODELS; POLYCYCLIC AROMATIC HYDROCARBONS; RISK ASSESSMENT; TUMORS;

HRT MODEL; INCENSE BURNING; PBPK MODEL; TEMPLES;

HEALTH RISKS;

BENZO[A]PYRENE; POLYCYCLIC AROMATIC HYDROCARBON;

BURNING; HEALTH RISK; PAH; PARTICULATE MATTER;

AIRBORNE PARTICLE; ARTICLE; CANCER INCIDENCE; CANCER RISK; CARCINOGENIC ACTIVITY; CONFIDENCE INTERVAL; DNA ADDUCT; DOSE RESPONSE; ENVIRONMENTAL EXPOSURE; HILL REACTION; LEUKOCYTE; LUNG CANCER; LUNG INTERSTITIUM; LUNG TUMOR; PARTICLE SIZE; PARTICULATE MATTER; PRIORITY JOURNAL; RISK ASSESSMENT;

AIR POLLUTANTS; AIR POLLUTION, INDOOR; CARCINOGENS, ENVIRONMENTAL; HUMANS; INHALATION EXPOSURE; LUNG NEOPLASMS; MODELS, BIOLOGICAL; PARTICLE SIZE; PARTICULATE MATTER; POLYCYCLIC HYDROCARBONS, AROMATIC; RELIGION; RESPIRATORY SYSTEM; RISK ASSESSMENT; TAIWAN;

EID: 33751001301     PISSN: 00489697     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2006.08.012     Document Type: Article

References (52)

1. Andersen M.E., Clewell H.J., Gargas H.L., Smith F.A., and Reitz R.H. Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. Toxicol Appl Pharmacol 87 (1987) 185-205
2. Armstrong B., Hutchinson E., Unwin J., and Fletcher T. Lung cancer risk after exposure to polycyclic aromatic hydrocarbons: a review and meta-analysis. Environ Health Perspect 112 (2004) 970-978
3. Ballesta P.P., De Salgar E., and Kotzias D. State of the art of the PAHs' analysis in ambient air. Fresenius Environ Bull 8 (1999) 499-505
4. Boffetta P., Jourenkova N., and Gustavsson P. Cancer risk from occupational and environmental exposure to polycyclic aromatic hydrocarbons. Cancer Causes Control 8 (1997) 444-472
5. Bostrom C.E., Gerde P., Hanberg A., Jernstrom B., Johansson C., Kyrklund T., et al. Cancer risk assessment, indicators, and guidelines for polycyclic aromatic hydrocarbons in the ambient air. Environ Health Perspect 110 (2002) 451-489
6. Chen H.W. Environmental exposure to nitrated polycyclic aromatic hydrocarbons in the Taiwanese temple. Bull Environ Contam Toxicol 74 (2005) 399-406
7. Chen J.W., Liao C.M., and Chen S.C. Compartmental human respiratory tract modeling of airborne dust exposure from feeding in swine buildings. J Air Waste Manage Assoc 54 (2004) 331-341
8. Chuang HC, 2005. Effects of temple particles on inflammatory reaction and endothelial dysfunction by human coronary artery endothelial cell. MS Thesis, National Taiwan University, Taipei, Taiwan ROC.
9. Clark L.H., Setzer R.W., and Barton H.A. Framework for evaluation of physiologically-based pharmacokinetic models for use in safety or risk assessment. Risk Anal 24 (2004) 1697-1717
10. Clewell H.J., and Andersen M.E. Applying mode-of-action and pharmacokinetic considerations in contemporary cancer risk assessments: an example with trichloroethylene. Crit Rev Toxicol 34 (2004) 385-445
11. Clewell H.J., Gentry P.R., Kester J.E., and Andersen M.E. Evaluation of physiologically based pharmacokinetic models in risk assessment: an example with perchloroethylene. Crit Rev Toxicol 35 (2005) 413-433
12. Culp S.J., Gaylor D.W., Winslow G.S., Goldstein L.S., and Beland F.A. A comparison of the tumors induced by coal tar and benzo(a)pyrene in a 2-year bioassay. Carcinogenesis 19 (1998) 117-124
13. Dennison J.E., Andersen M.E., Clewell H.J., and Yang R.S.H. Development of a physiologically based pharmacokinetic model for volatile fractions of gasoline using chemical lumping analysis. Environ Sci Technol 38 (2004) 5674-5681
14. Fang G.C., Chu C.C., Wu Y.S., and Fu P.P.C. Emission characters of particulate concentrations and dry deposition studies for incense burning at a Taiwanese temple. Toxicol Ind Health 18 (2002) 183-190
15. Fang G.C., Chang C.N., Chu C.C., Wu Y.S., Fu P.P.C., Chang S.C., et al. Fine (PM2.5), coarse (PM2.5-10), and metallic elements of suspended particulates for incense burning at Tzu Yun Yen temple in central Taiwan. Chemosphere 51 (2003) 983-991
16. Fitzgerald D.J., Robinson N.I., and Pester B.A. Application of benzo(a)pyrene end coal tar tumor dose-response date to a modified benchmark dose method of guideline development. Environ Health Perspect 112 (2004) 1341-1346
17. Georgopoulos P.G., Walia A., Roy A., and Lioy P.J. Integrated exposure and nose modeling and analysis system .1. Formulation and testing of microenvironmental and pharmacokinetic components. Environ Sci Technol 31 (1997) 17-27
18. Goldstein L.S. To BaP or not to BaP? That is the question. Environ Health Perspect 109 (2001) A356-A357
19. Heinrich U., Roller M., and Pott F. Estimation of a lifetime unit lung cancer risk for benzo[a]pyrene based on tumour rates in rats exposed to coal tar/pitch condensation aerosol. Toxicol Lett 72 (1994) 155-161
20. Ho C.K., Tseng W.R., and Yang C.Y. Adverse respiratory and irritant health effects in temple workers in Taiwan. J Toxicol Environ Health Part A 68 (2005) 1465-1470
21. Ho S.S.H., and Yu J.Z. Concentrations of formaldehyde and other carbonyls in environments affected by incense burning. J Environ Monit 4 (2002) 728-733
22. ICRP. Human respiratory tract model for radiological protection, a report of a task group of the international commission on radiological protection, ICRP Publication No. 66 (1994), Pergamon Press, New York
23. ICRP. Basic anatomical and physiological data for use in radiological protection: reference values, ICRP Publication No. 89 (2003), Pergamon Press, New York
24. Kriek E., Rojas M., Alexandrov K., and Bartsch H. Polycyclic aromatic hydrocarbon-DNA adducts in humans: relevance as biomarkers for exposure and cancer risk. Mut Res Fundam Mol Mech Mutagen 400 (1998) 215-231
25. Lazaridis M., Broday D.M., Hov O., and Georgopoulos P.G. Integrated exposure and dose modeling and analysis system: 3. Deposition of inhaled particles in the human respiratory tract. Environ Sci Technol 35 (2001) 3727-3734
26. Lee S.C., and Wang B. Characteristics of emissions of air pollutants from burning of incense in a large environmental chamber. Atmos Environ 38 (2004) 941-951
27. Lewtas J., Walsh D., Williams R., and Dobias L. Air pollution exposure DNA adduct dosimetry in humans and rodents: evidence for non-linearity at high doses. Mut Res Fundam Mol Mech Mutagen 378 (1997) 51-63
28. Li D.H., Firozi P.F., Wang L.E., Bosken C.H., Spitz M.R., Hong W.K., et al. Sensitivity to DNA damage induced by benzo(a)pyrene diol epoxide and risk of lung cancer: a case-control analysis. Cancer Res 61 (2001) 1445-1450
29. Liao C.M., and Luo W.C. Use of temporal/seasonal- and size-dependent bioaerosol data to characterize the contribution of outdoor fungi to residential exposures. Sci Total Environ 347 (2005) 78-97
30. Lin T.C., Chang F.H., Hsieh J.H., Chao H.R., and Chao M.R. Characteristics of polycyclic aromatic hydrocarbons and total suspended particulate in indoor and outdoor atmosphere of a Taiwanese temple. J Hazard Mater 95 (2002) 1-12
31. 10 and particle-bound polycyclic aromatic hydrocarbons under two ventilation conditions. Indoor Air 13 (2003) 194-199
32. Malcolm H.M., and Dobson S. The calculation of an environmental assessment level (EAL) for atmospheric PAHs using relative potencies (1994), Department of the Environment, London, UK 34-46
33. Mielke H., Gundert A., Abraham K., and Gundert-Remy U. Acute inhalative exposure assessment: derivation of guideline levels with special regard to sensitive subpopulations and time scaling. Toxicology 214 (2005) 256-267
34. NHMRC. 1999. Toxicity Assessment for Carcinogenic Soil Contaminants. Canberra, Australia: National Health and Medical Research Council. Available: http://www.health.gov.au:80/nhmrc/publications/synopses/eh21syn.htm.
35. Nisbet I.C.T., and LaGoy P.K. Toxic equivalency factors (TEFs) for polycyclic aromaic hydrocarbons (PAHs). Regul Toxicol Pharmacol 16 (1992) 290-300
36. Peluso M., Ceppi M., Munnia A., Puntoni R., and Parodi S. Analysis of 13 P-32-DNA postlabeling studies on occupational cohorts exposed to air pollution. Am J Epidemiol 153 (2001) 546-558
37. Poirier M.C. Chemical-induced DNA damage and human cancer risk. Nat Rev Cancer 4 (2004) 630-637
38. Pope C.A., Burnett R.T., Thun M.J., Calle E.E., Krewski D., Ito K., et al. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. J Am Med Assoc 287 (2002) 1132-1141
39. Pope C.A., Burnett R.T., Thurston G.D., Thun M.J., Calle E.E., Krewski D., et al. Cardiovascular mortality and long-term exposure to particulate air pollution-epidemiological evidence of general pathophysiological pathways of disease. Circulation 109 (2004) 71-77
40. Poulin P., and Krishnan K. A biologically-based algorithm for predicting human tissue: blood partition coefficients of organic chemicals. Hum Exp Toxic 14 (1995) 273-280
41. Poulin P., and Theil F.P. Prediction of pharmacokinetics prior to in vivo studies: 1. Mechanism-based prediction of volume of distribution. J Pharm Sci 91 (2002) 129-156
42. Pufulete M., Battershill J., Boobis A., and Fielder R. Approaches to carcinogenic risk assessment for polycyclic aromatic hydrocarbons: a UK perspective. Regul Toxicol Pharmacol 40 (2004) 54-66
43. Ramsey J.C., and Andersen M.E. A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans. Toxicol Appl Pharmacol 73 (1984) 159-175
44. Reddy M.B., Yang R.S.H., Clewell H.J., and Andersen M.E. Physiologically Based Pharmacokinetic Modeling: Science and Applications (2005), Wiley, New York
45. RIVM. Integrated Criteria Document PAHs. 758474011:1-199 (1989), National Institute of Public Health and Environmental Protection, Bilthoven
46. Smith L.E., Denissenko M.F., Bennett W.P., Li H.Y., Amin S., Tang M.S., et al. Targeting of lung cancer mutational hotspots by polycyclic aromatic hydrocarbons. J Nat Cancer Inst 92 (2000) 803-811
47. Sun Q., Wang A., Jin X., Natanzon A., Duquaine D., Brook R.D., et al. Long-term air pollution exposure and acceleration of atherosclerosis and vascular inflammation in an animal model. J Am Med Assoc 294 (2005) 3003-3010
48. Thyssen J., Althoff J., Kimmerle G., and Mohr U. Inhalation studies with benzo[a]pyrene in Syrian golden hamsters. J Nat Cancer Inst 66 (1981) 575-577
49. Vineis P., and Husgafvel-Pursiainen K. Air pollution and cancer: biomarker studies in human populations. Carcinogenesis 26 (2005) 1846-1855
50. WHO. Air quality guidelines for Europe. WHO regional publications vol. 91 (2000), WHO Regional Office for Europe, Copenhagen
51. Wiersma D.A., and Roth R.A. The prediction of benzo[a]pyrene clearance by rat liver and lung from enzyme kinetic data. Mol Pharmacol 24 (1983) 300-308
52. Yang H.H., Jung R.C., Wang Y.F., and Hsieh L.T. Polycyclic aromatic hydrocarbon emissions from joss paper furnaces. Atmos Environ 39 (2005) 3305-3312